1 year return (CAGR)
-22.06%
Prime Medicine, Inc. Common Stock Exchange (NASDAQ, USD)
PRME
3.18
+0.05 (+1.60%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-36.34%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
576.78M
Price/Sales
141.61
Ent value
738.56M
Price/Book
14.49
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
91.50%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.12 |
| Daily high | 3.28 |
| Daily low | 3.10 |
| Daily Volume | 1.62M |
| All-time high | 21.12 |
| 1y analyst estimate | 7.11 |
| Beta | 2.35 |
| EPS (TTM) | -1.06 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PRME | S&P500 | |
| Current price drop from All-time high | -84.94% | -2.19% |
| Highest price drop | -94.55% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.61% | -10.68% |
| Avg time to new high | 109 days | 12 days |
| Max time to new high | 969 days | 1805 days |
News
